Research Interest: - Functional Genomics and Computational Drug Discovery
From the bustling academic walls of Kaduna State University to the cutting-edge laboratories of Covenant University, Abednego Shekari has been on a transformative journey to revolutionize drug discovery. His passion stems from an urgent global crisis – the increasing mortality rates from diseases such as malaria, and cancer. This relentless drive to find novel treatment solutions led him to pursue a Master’s in Bioinformatics, where he is using computational approaches to identify new drug targets and potential therapeutic candidates against Anopheles gambiae - the vector that transmits malaria parasites.
Additionally, his academic excellence and research aspirations earned him the highly distinguished and competitive Covenant Applied Informatics and Communication Africa Centre of Excellence (CApIC-ACE) Award, funded by the World Bank-ACE-IMPACT project (2019-2024). As a research assistant at CApIC-ACE, he is actively engaged in bioinformatics research aiming at discovering breakthrough treatments.
Receiving this scholarship was a defining moment in his career. “It was mind-blowing,” he recalls, “because it means I can contribute significantly to drug discovery and develop innovative treatment options for diseases that seemed incurable.” His long-term vision is to become a leading researcher in drug discovery, developing groundbreaking solutions that enhance human life.
For Abednego Shekari, science is a journey of faith. “There is no disease that is incurable,” he asserts. “The solutions are out there – we just need to find them.”
